0001437749-17-006827.txt : 20170419 0001437749-17-006827.hdr.sgml : 20170419 20170419213918 ACCESSION NUMBER: 0001437749-17-006827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170417 FILED AS OF DATE: 20170419 DATE AS OF CHANGE: 20170419 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUTERA INC CENTRAL INDEX KEY: 0001162461 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770492262 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 94005 MAIL ADDRESS: STREET 1: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: ALTUS MEDICAL INC DATE OF NAME CHANGE: 20011119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laber Larry CENTRAL INDEX KEY: 0001697193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50644 FILM NUMBER: 17771203 MAIL ADDRESS: STREET 1: C/O CUTERA, INC. STREET 2: 3240 BAYSHORE BLVD CITY: BRISBANE STATE: CA ZIP: 94005 4 1 rdgdoc.xml FORM 4-LL X0306 4 2017-04-17 0001162461 CUTERA INC CUTR 0001697193 Laber Larry C/O CUTERA, INC. 3240 BAYSHORE BLVD BRISBANE CA 94005 1 EVP, North America Sales COMMON 2017-04-17 4 M 0 2076 10.03 A 78852 D COMMON 2017-04-17 4 S 0 2076 20.54 A 76776 D COMMON 2017-04-19 4 M 0 100 10.03 A 76876 D COMMON 2017-04-19 4 S 0 100 20.50 A 76776 D Employee Stock Option (Right to Buy) 10.03 2017-04-17 4 M 0 2076 0 D 2015-09-11 2021-10-24 Common Stock 30000 27924 D Employee Stock Option (Right to Buy) 10.03 2017-04-19 4 M 0 100 0 D 2015-09-11 2021-10-24 Common Stock 30000 27824 D Stock sold pursuant to a 10b5-1 trading plan. Stock sold in open market transactions pursuant to a 10b5-1 plan at prices that ranged from $20.50 to $20.65 with $20.54 being the average. The reporting person undertakes to provide to Cutera, Inc., any security holder of Cutera, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Larry Laber 2017-04-19